01 12AbbVie Corporation
01 22807847
02 22812261
03 22884539
04 22901810
05 12942823
06 22948902
07 12992722
01 12GLECAPREVIR | PIBRENTASVIR
01 5GRANULES
02 7TABLET
01 22031-09-20
02 22031-10-12
03 22033-09-17
04 22034-03-14
05 12035-04-01
06 22035-06-05
07 12036-07-18
Patent Expiration Date : 2031-09-20
Date Granted : 2017-02-21
Brand Name : MAVIRET
Patent Number : 2812261
Filing Date : 2011-09-20
Strength per Unit : 100 mg / 40 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-09-20
Date Granted : 2017-02-21
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-10-12
Date Granted : 2016-09-20
Brand Name : MAVIRET
Patent Number : 2807847
Filing Date : 2011-10-12
Strength per Unit : 100 mg / 40 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-10-12
Date Granted : 2016-09-20
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-03-14
Date Granted : 2019-01-08
Brand Name : MAVIRET
Patent Number : 2901810
Filing Date : 2014-03-14
Strength per Unit : 100 mg / 40 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2034-03-14
Date Granted : 2019-01-08
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2033-09-17
Date Granted : 2022-06-21
Brand Name : MAVIRET
Patent Number : 2884539
Filing Date : 2013-09-17
Strength per Unit : 100 mg / 40 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2033-09-17
Date Granted : 2022-06-21
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2035-06-05
Date Granted : 2022-11-22
Brand Name : MAVIRET
Patent Number : 2948902
Filing Date : 2015-06-05
Strength per Unit : 100 mg / 40 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2035-06-05
Date Granted : 2022-11-22
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2035-04-01
Date Granted : 2023-01-03
Brand Name : MAVIRET
Patent Number : 2942823
Filing Date : 2015-04-01
Strength per Unit : 100 mg / 40 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2035-04-01
Date Granted : 2023-01-03
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2036-07-18
Date Granted : 2023-10-17
Brand Name : MAVIRET
Patent Number : 2992722
Filing Date : 2016-07-18
Strength per Unit : 100 mg / 40 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2036-07-18
Date Granted : 2023-10-17
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2033-09-17
Date Granted : 2022-06-21
Brand Name : MAVIRET
Patent Number : 2884539
Filing Date : 2013-09-17
Strength per Unit : 50 mg / 20 mg
Dosage Form : GRANULES
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2033-09-17
Date Granted : 2022-06-21
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-10-12
Date Granted : 2016-09-20
Brand Name : MAVIRET
Patent Number : 2807847
Filing Date : 2011-10-12
Strength per Unit : 50 mg / 20 mg
Dosage Form : GRANULES
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-10-12
Date Granted : 2016-09-20
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-09-20
Date Granted : 2017-02-21
Brand Name : MAVIRET
Patent Number : 2812261
Filing Date : 2011-09-20
Strength per Unit : 50 mg / 20 mg
Dosage Form : GRANULES
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-09-20
Date Granted : 2017-02-21
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
